ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 150 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $286,315 | +18.7% | 7,080 | +36.5% | 0.01% | -18.2% |
| Q4 2022 | $241,206 | -23.9% | 5,185 | -15.2% | 0.01% | +10.0% |
| Q3 2022 | $317,000 | +3.3% | 6,116 | -6.5% | 0.01% | +11.1% |
| Q2 2022 | $307,000 | -28.8% | 6,544 | +5.1% | 0.01% | 0.0% |
| Q1 2022 | $431,000 | -5.9% | 6,227 | +1.4% | 0.01% | 0.0% |
| Q4 2021 | $458,000 | +10.6% | 6,143 | -16.8% | 0.01% | +12.5% |
| Q3 2021 | $414,000 | +58.6% | 7,381 | +23.9% | 0.01% | +100.0% |
| Q2 2021 | $261,000 | -12.1% | 5,957 | -3.6% | 0.00% | -20.0% |
| Q1 2021 | $297,000 | -26.8% | 6,179 | -36.7% | 0.01% | -44.4% |
| Q4 2020 | $406,000 | -19.4% | 9,766 | -13.1% | 0.01% | -43.8% |
| Q3 2020 | $504,000 | +76.8% | 11,244 | +93.2% | 0.02% | +60.0% |
| Q2 2020 | $285,000 | – | 5,820 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |